Skip to search formSkip to main contentSkip to account menu

MK-0974

Known as: MK 0974, MK0974 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Objective The objective of this article is to assess the effects of sumatriptan monotherapy, telcagepant monotherapy, and their… 
Review
2011
Review
2011
Telcagepant (MK0974) is one of several calcitonin-gene-related peptide antagonists in development as a potential treatment for… 
Review
2011
Review
2011
Telcagepant (MK-0974) is a novel calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials… 
Highly Cited
2010
Highly Cited
2010
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT * Calcitonin gene-related peptide (CGRP) was first described as a potent vasodilator… 
Review
2008
Review
2008
The neuropeptide calcitonin gene‐related peptide (CGRP) is implicated in the underlying pathology of migraine. Serum levels of… 
Review
2008
Review
2008
Migraine is a complex neurological disorder in which genetic and environmental factors interact. At present, frontline therapies… 
2008
2008
Three things attracted me to headache some years ago: the pathophysiology of the disorder presented to students—the vascular…